Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinomaKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology and Hepatology|2011Cited by 90
Clinical utility of high-throughput glycome analysis in patients with pancreatic cancerKazuhiro Nouso, Kazuhide Yamamoto, Maho Amano et al.|Journal of Gastroenterology|2013Cited by 54
Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative ColitisKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|PLoS ONE|2013Cited by 51
Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoproteinKazuhiro Nouso, Kazuhide Yamamoto, Yoshiyuki Kobayashi et al.|Journal of Gastroenterology and Hepatology|2011Cited by 36
Prognotic impact of serum follistatin in patients with hepatocellular carcinomaTakeshi Tomoda, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology and Hepatology|2013Cited by 22